Global Vitamin D Therapy Market
Global Vitamin D Therapy Market was valued US$ 883.21 Mn in 2019, and expected to reach US$ 2218.23 Mn by 2027, at a CAGR of 12.2 % during forecast period.
The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.
The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding global vitamin D therapy market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, report also focuses on competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, SWOT analysis to address questions of shareholders to prioritizing the efforts and investment in near future to emerging segment in global vitamin D therapy market.
The major factors behind the growth of the global vitamin D therapy market are growing increased awareness of Vitamin D benefits in bone diseases, and growing focus on healthy diets among consumers. Further, presence of a large target patient population is also boost the global vitamin D therapy market during the forecast period. Emerging economies with growing healthcare expenditures are expected to offer tremendous opportunities for the growth of the global vitamin D therapy market. On the other hand, the fortification of foods is likely to challenge the global vitamin D therapy market growth to a certain amount.
Based on the route of administration, the oral route accounted for the largest share of the vitamin D therapy market in 2017 and it is expected to growth at a significant rate during forecast period. This growth is mainly attributed to, the ease of administration, better pharmacokinetic and pharmacodynamic activity, and a higher preference for the oral route.
Based on the purchasing pattern, the prescription drugs segment accounted for the major shares of the global vitamin D therapy market. The large share of this segment can be attributed to the fact that vitamin D deficiency is mostly diagnosed by registered medical physicians that provide prescriptions for appropriate medications.
Based on the applications, the osteoporosis segment accounted for the largest share of the global vitamin D therapy market in 2017, owing to the increasing incidence of falls and fractures in senior adults due to the higher level of parathyroid hormones and the poor absorption of calcium from their diets.
Geographically, the Asia Pacific region dominated the vitamin D therapy market in 2017 and it is expected to grow at a high CAGR during the forecast period. This growth is mainly attributed to the Asia Pacific have the most populated countries such as China and India. The increasing awareness about vitamin D deficiency among those countries and supportive government policies and programs for the implementation of vitamin D deficiency treatment plans, increasing incidence of vitamin D deficiency, heavy air pollution, sedentary lifestyles, atypical diets, decreasing sun exposure, and rising malnutrition level.
Author Signature :
Global Vitamin D Therapy Market
About Maximize Market Research: Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healt..